Literature DB >> 27622568

Reverse Phase Protein Arrays for Compound Profiling.

Nathan Moerke1, Mohammad Fallahi-Sichani2.   

Abstract

Reverse phase protein arrays (RPPAs), also called reverse phase lysate arrays (RPLAs), involve immobilizing cell or tissue lysates, in small spots, onto solid supports which are then probed with primary antibodies specific for proteins or post-translational modifications of interest. RPPA assays are well suited for large-scale, high-throughput measurement of protein and PTM levels in cells and tissues. RPPAs are affordable and highly multiplexable, as a large number of arrays can readily be produced in parallel and then probed separately with distinct primary antibodies. This article describes a procedure for treating cells and preparing cell lysates, as well as a procedure for generating RPPAs using these lysates. A method for probing, imaging, and analyzing RPPAs is also described. These procedures are readily adaptable to a wide range of studies of cell signaling in response to drugs and other perturbations. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  BRAF; antibodies; cell signaling; fluorescence; melanoma; reverse phase protein arrays

Mesh:

Year:  2016        PMID: 27622568      PMCID: PMC5613289          DOI: 10.1002/cpch.9

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  15 in total

1.  Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays.

Authors:  Michael A Stiffler; Viara P Grantcharova; Mark Sevecka; Gavin MacBeath
Journal:  J Am Chem Soc       Date:  2006-05-03       Impact factor: 15.419

2.  State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling.

Authors:  Mark Sevecka; Gavin MacBeath
Journal:  Nat Methods       Date:  2006-10       Impact factor: 28.547

Review 3.  Collecting and organizing systematic sets of protein data.

Authors:  John G Albeck; Gavin MacBeath; Forest M White; Peter K Sorger; Douglas A Lauffenburger; Suzanne Gaudet
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

Review 4.  Dissecting protein function and signaling using protein microarrays.

Authors:  Alejandro Wolf-Yadlin; Mark Sevecka; Gavin MacBeath
Journal:  Curr Opin Chem Biol       Date:  2009-08-05       Impact factor: 8.822

5.  Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling.

Authors:  Mark Sevecka; Alejandro Wolf-Yadlin; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2011-02-04       Impact factor: 5.911

6.  A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins.

Authors:  Katrin Luckert; Taranjit S Gujral; Marina Chan; Mark Sevecka; Thomas O Joos; Peter K Sorger; Gavin Macbeath; Oliver Pötz
Journal:  Sci Signal       Date:  2012-01-10       Impact factor: 8.192

Review 7.  Vemurafenib: the first drug approved for BRAF-mutant cancer.

Authors:  Gideon Bollag; James Tsai; Jiazhong Zhang; Chao Zhang; Prabha Ibrahim; Keith Nolop; Peter Hirth
Journal:  Nat Rev Drug Discov       Date:  2012-10-12       Impact factor: 84.694

8.  Profiling receptor tyrosine kinase activation by using Ab microarrays.

Authors:  Ulrik B Nielsen; Mike H Cardone; Anthony J Sinskey; Gavin MacBeath; Peter K Sorger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

9.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

Review 10.  Targeting the cancer kinome through polypharmacology.

Authors:  Zachary A Knight; Henry Lin; Kevan M Shokat
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.